FDAnews
www.fdanews.com/articles/192259-masimos-infant-hemoglobin-monitor-receives-ce-mark

Masimo’s Infant Hemoglobin Monitor Receives CE Mark

August 6, 2019

Masimo gained the CE Mark for its SpHb hemoglobin monitor for newborns and infant patients that weigh less than 6.6 lbs.

The device is a noninvasive, continuous monitor that measures total hemoglobin, oxygen saturation and methemoglobin. It isn’t intended to replace laboratory blood testing, Masimo said.

With its receipt of the CE Mark, the device is now available to patients of all ages in the EU.

View today's stories